CARBIOTIX AB (CRBX.ST)

SEK 8.58

(-2.72%)

Market Cap (In SEK)

18.02 Million

Revenue (In SEK)

1.46 Million

Net Income (In SEK)

-13.47 Million

Avg. Volume

10.59 Thousand

Currency
SEK
Country
Industrials
Open
-
Prev. Close
-
Day Range
-
Year Range
3.58-97.0
PE
-
EPS
-
Beta Value
1.058
ISIN
SE0013016128
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industrials
Industry
Specialty Business Services
CEO
Mr. Erik Deaner
Employee Count
-
Website
http://www.carbiotix.com
Ipo Date
2019-10-21
Details
Carbiotix AB is a pre-clinical stage therapeutics company. It engages in the provision of products and medicines that produce good bacteria from intestine to counter metabolic and chronic diseases. The company was founded in 2014 and is headquartered in Lund, Sweden.